Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation [5]

Transplantation

Volumn 78, Issue 3, 2004, Pages 488-489

  Ogawa, Hiroyasu ^a   Ikegame, Kazuhiro ^a   Kawakami, Manabu ^a   Tsuboi, Akihiro ^a   Kim, Eui Ho ^a   Hosen, Naoki ^a   Murakami, Masaki ^a   Fujioka, Tatsuya ^a   Masuda, Tomoki ^a   Taniguchi, Yuki ^a   Yoshihara, Satoshi ^a   Tatekawa, Toyoshi ^a   Oka, Yoshihiro ^a   Kawase, Ichiro ^a   Soma, Toshihiro ^b   Oji, Yusuke ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; LETTER; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PRIORITY JOURNAL;

FATAL OUTCOME; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; LYMPHOCYTE DEPLETION; MALE; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 4143150685     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000128627.28212.D7     Document Type: Letter

References (4)

1. Giralt S, Thall PF, Khouri I, et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631.
2. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756.
3. Tamaki H, Ikegame K, Kawakami M, et al. Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. Leukemia 2003; 17: 2052.
4. Ogawa H, Tamaki H, Ikegame K, et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003; 101: 1698.